STEVE TOLLE, PARTNER

Steve brings 30 years of commercial healthcare technology expertise in the areas of strategy, business development, and product management to HLM. Steve has spent his career helping to develop and manage some of the most important themes in healthcare innovation and investment today, including artificial intelligence, diagnostic imaging/medical devices, electronic health records, population health, managed care, and value-based pharmaceutical pricing. Currently, Steve is a director at b.well Connected Health and HealthEC, and a board observer at Nordic Consulting, and Vaxcare. Steve also serves on the AI Advisory Board at Guerbet. He has previously served as a director at LetsGetChecked.

Prior to joining HLM, Steve was global Vice President of Strategy at IBM Watson Health. Previously, he was Chief Strategy Officer at Merge Healthcare (acquired by IBM for $1B in 2015). Steve led the effort to move Merge Healthcare into the AI space and played a key role in the successful sale to IBM. As part of the Merge/Watson Health leadership team, Steve worked on over $3.6 billion of strategic M&A deal opportunities.

Other notable previous roles include Senior Vice President/General Manager at Optum, Vice President of Product Management at Allscripts, and Director of Product Management at Pfizer.